Early prophylactic thyroidectomy for RETmutation-positive MEN 2B

Pediatrics International

Volumn 51, Issue 4, 2009, Pages 590-593

  Engiz, Ozlem ^a,b   Ocal, Gonul ^b   Siklar, Zeynep ^b   Erdogan, Murat ^b   Kologlu, Meltem ^b   Percinel, Sibel ^b   Bilir, Pelin ^b   Berberoglu, Merih ^b  

^a Yesilvadi Sok Konut Kuleleri   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Brain injury; Early prophylactic thyroidectomy; Hypothyroidism; MEN type 2B; RET mutation

Indexed keywords

CALCITONIN; CALCIUM CARBONATE; COLECALCIFEROL; GLUCONATE CALCIUM; LEVOTHYROXINE; PENTAGASTRIN; PROTEIN RET; THYROTROPIN;

ARTICLE; CALCITONIN BLOOD LEVEL; CASE REPORT; CODON; DRUG WITHDRAWAL; EXON; GENE MUTATION; HETEROZYGOSITY; HISTOPATHOLOGY; HUMAN; HYPERPLASIA; HYPOTHYROIDISM; IMMUNOHISTOCHEMISTRY; INFANT; MALE; NEUROMA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; RADIOIMMUNOASSAY; RESTRICTION FRAGMENT; SIPPLE SYNDROME; THYROID FUNCTION; THYROID PARAFOLLICULAR CELL; THYROIDECTOMY; TONGUE TUMOR; ULTRASOUND;

ELECTROPHORESIS, AGAR GEL; HUMANS; INFANT; MALE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B; POINT MUTATION; PRECANCEROUS CONDITIONS; PROTO-ONCOGENE PROTEINS C-RET; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 68349128098     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2009.02870.x     Document Type: Article

References (15)

1. Peczkowska M, Januszewicz A. Multiple endocrine neoplasia type 2. Fam. Cancer 2005 4 : 25 36.
2. Mulligan LM, Kwok JB, Healey CS et al. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993 363 : 458 60.
3. Donis-Keller H, Dou S, Chi D et al. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum. Mol. Genet. 1993 2 : 851 56.
4. Brandi ML, Gagel RF, Angeli A et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J. Clin. Endocrinol. Metab. 2001 86 : 5658 71.
5. Sanso GE, Domene HM, Garcia R et al. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: Presence of C-cell malignant disease in asymptomatic carriers. Cancer 2002 94 : 323 30.
6. van Heurn LW, Schaap C, Sie G et al. Predictive DNA testing for multiple endocrine neoplasia 2: A therapeutic challenge of prophylactic thyroidectomy in very young children. J. Pediatr. Surg. 1999 34 : 568 71.
7. Wolfe HJ, Melvin KEW, Cevri-Skinner SJ et al. C-cell hyperplasia preceding medullary thyroid carcinoma. N. Engl. J. Med. 1973 289 : 437 41.
8. DeLellis RA. C-cell hyperplasia: A current perspective. Adv. Anat. Pathol. 1997 4 : 17 22.
9. Maeda S, Namba H, Takamura N et al. A single missense mutation in codon 918 of the RET proto-oncogene in sporadic medullary thyroid carcinomas. Endocr. J. 1995 42 : 245 50.
10. Pausova Z, Soliman E, Amizuka N et al. Role of the RET proto-oncogene in sporadic hyperparathyroidism and in hyperparathyroidism of multiple endocrine neoplasia type 2. J. Clin. Endocrinol. Metab. 1996 81 : 2711 18.
11. Skinner MA, DeBenedetti MK, Moley JF, Norton JA, Wells SA Jr. Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B. J. Pediatr. Surg. 1996 31 : 177 82.
12. Hofstra RM, Landsvater RM, Ceccherini I et al. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 1994 367 : 375 76.
13. Eng C, Clayton D, Schuffenecker I et al. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2: International RET mutation consortium analysis. JAMA 1996 276 : 1575 79.
14. Eng C, Smith DP, Mulligan LM et al. Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours. Hum. Mol. Genet. 1994 3 : 237 41.
15. Niccoli-Sire P, Murat A, Baudin E et al. Early or prophylactic thyroidectomy in MEN 2/FMTC gene carriers: Results in 71 thyroidectomized patients. The French Calcitonin Tumours Study Group (GETC). Eur. J. Endocrinol. 1999 141 : 468 74.